Cancer Treatment Reviews
Volume 26, Issue 2 , Pages 103-125, April 2000

Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives☆☆☆

The Department of Surgery, 251 Hellenic Air Force (HAF) Hospital, Messogion and Katehaki Str, Athens, 115 25, Greece

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ 1This trial has since been published. See Firher B, Dignam J, Wolmark N et al. Tamoxifen in the treatment of intraductal breast cancer. National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial. Lancet 1999;353: 1993–2000.

☆☆ 2Some authors have proposed larger tumor size (> 4 cm) as an indication for mastectomy (3, 143). However, the larger the tumour, the more difficult to achieve complete tumour removal with satisfactory cosmetic result

PII: S0305-7372(99)90149-4

doi:10.1053/ctrv.1999.0149

Cancer Treatment Reviews
Volume 26, Issue 2 , Pages 103-125, April 2000

Article Tools